Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern

Added 116 days ago (20.01.2022)
Authors: Rai, D. K., Yurgelonis, I., McMonagle, P., Rothan, H. A., Hao, L., Gribenko, A., Titova, E., Kreiswirth, B., White, K. M., Zhu, Y., Anderson, A. S., Cardin, R. D.
Source: bioRxiv
Read article